
A novel schedule of zzso administration has been developed for zzso zzso zzso In combination with the zzso synthesis inhibitor zzso zzso has been given as a 24-hour infusion, repeated zzso a dose of zzso zzso is well zzso To identify a suitable dose of zzso as a single agent on this schedule, we treated 26 patients at doses ranging from zzso to zzso zzso per zzso zzso of the patients had failed previous therapy, and most were symptomatic from their zzso Over half of the patients had zzso zzso zzso The zzso toxicity was zzso Grade 3 or 4 toxicity occurred at every level zzso Twenty-two of the 26 patients required therapy interruption because of zzso The severity of this toxicity indicated that escalation of zzso on this schedule beyond the zzso zzso known to be tolerated in the zzso regimen, would be zzso Two patients, both with previously zzso zzso cancer, had partial zzso lasting three and five months zzso This zzso schedule of zzso administration will be explored further in large-scale zzso zzso 

